Surrozen Inc. (NASDAQ: SRZN)
$9.25
-0.0773 ( -0.83% ) 1.9K
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
Market Data
Open
$9.25
Previous close
$9.33
Volume
1.9K
Market cap
$29.51M
Day range
$9.05 - $9.59
52 week range
$4.50 - $16.19
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Apr 26, 2024 |
| ars | Annual reports | 1 | Apr 23, 2024 |
| def | Proxies and info statements | 5 | Apr 23, 2024 |
| 4/a | Other | 1 | Apr 17, 2024 |
| 4/a | Other | 1 | Apr 17, 2024 |
| 10-k | Annual reports | 100 | Apr 10, 2024 |
| 4 | Insider transactions | 1 | Apr 08, 2024 |
| 4 | Insider transactions | 1 | Apr 08, 2024 |
| 4 | Insider transactions | 1 | Apr 08, 2024 |
| 4 | Insider transactions | 1 | Apr 08, 2024 |